HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target.
Pinduoduo Q3 Sales $4.99B Beat $4.31B Estimate
Pinduoduo (NASDAQ:PDD) reported quarterly sales of $4.99 billion which beat the analyst consensus estimate of $4.31 billion by 15.80 percent. This is a 49.54 percent increase over sales of $3.34 billion the same period